3.0
10. Juli 2022
Ehemaliger Mitarbeiter, mehr als 10 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Health care and pharmacy on-site RFC, back in the day before Covid-19 Beautiful campus Pleasant coworkers
Kontras
Rampant favoritism among senior management Inability to sustain product sales due to stiff competition and overpricing Total compensation lags the regional job market, way behind US market Non-nonsensical R&D reorganizations